An international research group led by chief physician Dr. Hana Alguel of the Second Medical Clinic of the Klinikum rechts der Isar (TUM - Technical University Munic) has identified a previously unknown mechanism by which pancreatic cancer. This mechanism could provide a novel therapy of previously classified as incurable disease.
Picture: Pancreatic cancer is often diagnosed in a late stage and is very agressive (source: TUM)
Economists at the Technical University of Munich (Technische Universitaet Muenchen, TUM) have developed a website that predicts individual stock trends. To this end, economists are using automatic text analysis methods to evaluate thousands of daily Twitter microblog messages, so-called "tweets". On www.TweetTrader.net current forecasts are available for all S&P 500 listed stocks.
Picture Source: TUM
Scientists from the Ludwig-Maximilians-University of Munich (LMU) show their research results: Immune defense of the body against tumours can be activated by a therapy with so-called CpG-DNA-oligonucleotides – these are short pieces of the hereditary molecule DNA. This treatment is tested currently as a possible cancer therapy. Now, however, some results point to the fact that the CpG therapy can also lead to an increase of so-called myeloid suppressor cells (MDSC). These immune cells suppress the body defense actively, thus counteracting the cancer therapy. Now, however, scientists around the outside lecturer Dr. Carole Bourquin of the department for clinical pharmacology of the medical centre of the Ludwig-Maximilians-University of Munich (LMU) could show for the first time that the CpG therapy switches off the MDSC, while it gets going their maturation.
Researchers in the medical centre rechts der Isar of the TUM (Technical University Munich) find helper cells for skin replacement tissue. Scientist of the clinic for plastic surgery and hand surgery (research management: Prof. Arndt Schilling) have discovered a possibility to supply skin replacement tissue faster with the necessary blood vessels.
Picture: Skin replacement tissue with Vascular Resident Endothelial Progenitor Cell (Source: Klinikum rechts der Isar)
A team of researchers led by LMU (Ludwig-Maximilians-University Munich) Professor Martin Kerschensteiner of the University’s Medical Center and Professor Thomas Misgeld from the TUM (Technical University of Munich) have found a previously unknown mechanism which explains how nerve-cell projections (axons) are destroyed in multiple sclerosis (MS). The results of the research show that this process is reversible if recognized and treated early. Therefore it could serve as a target for future therapeutic intervention. The results are published in the online-version of Nature Medicine at 11/03/27.
Picture: In multiple sclerosis, immune cells (green) attack nerve-cell projections or axons (blue). Light microscopy picture of the spinal cord of a mouse.